Hello, everyone. Nice to see you again. Another shiny day here on the Pharmalot corporate campus where the grounds are being spruced up in a long overdue move. What will today bring? Important meetings and deadlines, no doubt. As you ready yourself, here are a few items to help you along. Best of luck and catch you later...
Galapagos Widens Lung Drug Deal With Roche (Reuters)
Drugmakers Leave New Jersey's Medicine Chest Bare (NJ Spotlight)
Purdue Files Patent Infringement Suit Against Ranbaxy (Business Standard)
Merck And Glenmark Settle Zetia Patent Suit (Bloomberg News)
UK Drug Shortages May Last Until 2011 (PharmaTimes)
Proton Pump Inhibitors Increase Bone Fracture Risk (Los Angeles Times)
Cost Of Treating Cancer Doubles (Associated Press)
Roche Seeks Deal Approval In Accutane Suit (Madison-St. Clair Record)
2 Comments
Your article in NJ spotlight "Drugmakers etc.." was quite good. Too bad you didn't (couldn't?) flag it for PharmaLot content.
Ed: glad you put this story up on WED. It deserved it. I hope you don't mind that I flagged it on LinkedIn under RAPS NJ and the NJ Network. I should have added it (the link that is) to ISPE NJ as well; hope you won't mind. John